Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing risk factors and outcomes in patients with coronary chronic total occlusion

Official title: Risk Factors and Outcomes in Patients With Stable Coronary Artery Disease and Coronary Chronic Total Occlusion

Run by Ruijin Hospital · NCT06137521 · Data updated 2026-11-12

This study looks at how different treatments for coronary chronic total occlusion affect the long-term health of patients and what factors might influence their recovery.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment3000 (estimated)
SponsorRuijin Hospital
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedJanuary 1, 2010
Main results expectedDecember 31, 2026
Study endsMarch 1, 2027
Registry record updatedAugust 18, 2026
Trial IDNCT06137521 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with documented ischemia and chronic total occlusion lasting more than three months.

Probably not a fit

Patients with severe chronic heart failure, recent coronary interventions, or significant comorbidities such as malignancies or immune disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the risk factors and long-term outcomes of patients suffering from coronary chronic total occlusion (CTO) who are treated either with percutaneous coronary intervention or medical management. It focuses on understanding how various baseline characteristics and treatment modalities influence the prognosis of CTO patients, who typically face worse outcomes compared to those without CTO. The study will involve collecting clinical data and blood samples to identify factors that may contribute to the development of coronary collateral formation and overall patient outcomes. Conducted at a single center, this research seeks to enhance clinical decision-making for managing coronary artery disease.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies and better outcomes for patients with coronary chronic total occlusion.

How similar studies have gone: While there have been studies on coronary artery disease, this specific focus on chronic total occlusion and its risk factors is relatively novel and not extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years; Patients with angina or silent ischemia and documented ischemia; Patients with CTO ≥ 3months

Exclusion Criteria:

* eGFR\<15mL/(min·1.73m2); Chronic heart failure with NYHA grade ≥3; Had a history of coronary artery bypass grafting; Had received a percutaneous coronary intervention within the prior 3 months; Malignant tumor or immune system disorders; Pulmonary heart disease

Where it's running

  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.